126 related articles for article (PubMed ID: 24900413)
1. Preparation of Novel Pyrazolyl Guanidine as F1F0-ATPase Inhibitors: Patent Highlight.
Rosse G
ACS Med Chem Lett; 2012 Dec; 3(12):952. PubMed ID: 24900413
[No Abstract] [Full Text] [Related]
2. ATP synthase from bovine heart mitochondria: identification by proteolysis of sites in F0 exposed by removal of F1 and the oligomycin-sensitivity conferral protein.
Collinson IR; Fearnley IM; Skehel JM; Runswick MJ; Walker JE
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):639-45. PubMed ID: 7980427
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitory Effect of
Nehme H; Ayde H; El Obeid D; Sabatier JM; Fajloun Z
Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33218209
[TBL] [Abstract][Full Text] [Related]
4. Analysis of F1F0-ATPase from Helicobacter pylori.
McGowan CC; Cover TL; Blaser MJ
Infect Immun; 1997 Jul; 65(7):2640-7. PubMed ID: 9199431
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the F1F0-ATPase and the tightly-bound ATPase activities in submitochondrial particles from human term placenta.
Martínez F; Meaney A; Espinosa-García MT; Pardo JP; Uribe A; Flores-Herrera O
Placenta; 1996; 17(5-6):345-50. PubMed ID: 8829218
[TBL] [Abstract][Full Text] [Related]
6. F1F0-ATPase from Escherichia coli with mutant F0 subunits. Partial purification and immunoprecipitation of F1F0 complexes.
Vik SB; Simoni RD
J Biol Chem; 1987 Jun; 262(17):8340-6. PubMed ID: 2885319
[TBL] [Abstract][Full Text] [Related]
7. Effect of a novel inhibitory mAb against beta-subunit of F1F0 ATPase on HCC.
Wang J; Han Y; Liang J; Cheng X; Yan L; Wang Y; Liu J; Luo G; Chen X; Zhao L; Zhou X; Wu K; Fan D
Cancer Biol Ther; 2008 Nov; 7(11):1829-35. PubMed ID: 18836304
[TBL] [Abstract][Full Text] [Related]
8. Vacuolar H+-ATPase, but not mitochondrial F1F0-ATPase, is required for aluminum resistance in Saccharomyces cerevisiae.
Hamilton CA; Good AG; Taylor GJ
FEMS Microbiol Lett; 2001 Dec; 205(2):231-6. PubMed ID: 11750808
[TBL] [Abstract][Full Text] [Related]
9. Regulatory proteins of F1F0-ATPase: role of ATPase inhibitor.
Hashimoto T; Yoshida Y; Tagawa K
J Bioenerg Biomembr; 1990 Feb; 22(1):27-38. PubMed ID: 2140357
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of Arabidopsis thaliana mitochondrial F
Chen C; Meng Y; Shopan J; Whelan J; Hu Z; Yang J; Zhang M
J Plant Physiol; 2020 Nov; 254():153264. PubMed ID: 33032063
[TBL] [Abstract][Full Text] [Related]
11. mtDNA T8993G mutation-induced F1F0-ATP synthase defect augments mitochondrial dysfunction associated with hypoxia/reoxygenation: the protective role of melatonin.
Huang WY; Jou MJ; Peng TI
PLoS One; 2013; 8(11):e81546. PubMed ID: 24312318
[TBL] [Abstract][Full Text] [Related]
12. Overexpression, purification, and characterization of human and bovine mitochondrial ATPase inhibitors: comparison of the properties of mammalian and yeast ATPase inhibitors.
Ichikawa N; Ogura C
J Bioenerg Biomembr; 2003 Oct; 35(5):399-407. PubMed ID: 14740888
[TBL] [Abstract][Full Text] [Related]
13. The F1F0-ATPase complex from bovine heart mitochondria: the molar ratio of the subunits in the stalk region linking the F1 and F0 domains.
Collinson IR; Skehel JM; Fearnley IM; Runswick MJ; Walker JE
Biochemistry; 1996 Sep; 35(38):12640-6. PubMed ID: 8823202
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity.
Curti C; Mingatto FE; Polizello AC; Galastri LO; Uyemura SA; Santos AC
Mol Cell Biochem; 1999 Sep; 199(1-2):103-9. PubMed ID: 10544958
[TBL] [Abstract][Full Text] [Related]
15. Purification and reconstitution of the F1F0-ATP synthase from alkaliphilic Bacillus firmus OF4. Evidence that the enzyme translocates H+ but not Na+.
Hicks DB; Krulwich TA
J Biol Chem; 1990 Nov; 265(33):20547-54. PubMed ID: 2173711
[TBL] [Abstract][Full Text] [Related]
16. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities.
Bruno O; Ranise A; Bondavalli F; Schenone P; D'Amico M; Filippelli A; Filippelli W; Rossi F
Farmaco; 1993 Jul; 48(7):949-66. PubMed ID: 8397678
[TBL] [Abstract][Full Text] [Related]
17. Identification of the subunits of F1F0-ATPase from bovine heart mitochondria.
Walker JE; Lutter R; Dupuis A; Runswick MJ
Biochemistry; 1991 Jun; 30(22):5369-78. PubMed ID: 1827992
[TBL] [Abstract][Full Text] [Related]
18. The aleu207-->arg mutation in F1F0-ATP synthase from Escherichia coli. A model for human mitochondrial disease.
Hartzog PE; Cain BD
J Biol Chem; 1993 Jun; 268(17):12250-2. PubMed ID: 8509361
[TBL] [Abstract][Full Text] [Related]
19. Formation of the yeast F1F0-ATP synthase dimeric complex does not require the ATPase inhibitor protein, Inh1.
Dienhart M; Pfeiffer K; Schagger H; Stuart RA
J Biol Chem; 2002 Oct; 277(42):39289-95. PubMed ID: 12167646
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus salivarius Isolates of Varying Acid Tolerance Exhibit F1F0-ATPase Conservation.
Allen LL; Heng NCK; Tompkins GR
Caries Res; 2021; 55(4):288-291. PubMed ID: 34098556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
